Preparation method and application of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride
By using inexpensive raw materials and a non-pressurized reaction synthesis route, the problems of high cost and low safety in existing technologies have been solved, and the preparation of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride with high yield and high purity has been achieved, which is suitable for industrial production.
Patent Information
- Application Number
- CN202410161510.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-05
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-02-05
AI Technical Summary
The synthesis of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride in the prior art requires the use of precious metals such as palladium acetate and palladium on carbon as catalysts, which results in high cost, low safety, and the need for pressurized reaction, harsh preparation conditions, and low yield.
The target compound was prepared by using 1-chloro-5-fluoro-2-methyl-4-nitrobenzene as the starting material, reacting it with isopropanol in an alkaline system, and then reacting it with LiHMDS and methyl N-Boc-4-piperidinecarboxylate. After hydrolysis, acid removal, and reduction with a reducing agent, the target compound was finally obtained by adding hydrochloric acid, thus avoiding the use of precious metals and pressure reactions.
A low-cost and highly safe preparation process was achieved, with a yield of nearly 60% and a purity of up to 99.9%, making it suitable for large-scale production.
Smart Images

Figure CN118146138B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of drug synthesis, and particularly relates to a preparation method and application of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride. Background Art
[0002] Ceritinib is a highly effective second-generation ALK inhibitor. Its main function is to inhibit the ALK protein in tumor cells, effectively preventing cell growth and division, thereby effectively inhibiting the development and spread of tumors. It is of great significance for the treatment of cancer and tumors.
[0003] 2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride is a key intermediate of Ceritinib. Currently, the synthesis of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride requires the use of precious metal palladium acetate and palladium carbon for catalysis, resulting in a high cost of the raw material of Ceritinib, and the reaction can only be completed under pressure conditions, the preparation conditions are harsh, and the reaction is slow; in addition, the preparation process uses an excessive amount of sodium borohydride, which makes the safety risk of scaled-up production high, the safety is low, and the preparation yield is low (about 41%).
[0004] Therefore, there is an urgent need to provide a method for preparing 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride, which has low raw material cost, no need for pressurized reaction, high safety, is conducive to large-scale production, and the prepared 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride has high yield and high purity. Summary of the invention
[0005] The present invention aims to solve one or more technical problems existing in the above-mentioned prior art, and at least provide a beneficial choice or create conditions. Specifically, the present invention provides a method for preparing 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride, which has low raw material cost, no need for pressurized reaction, high safety, is conducive to scaled-up production, and the prepared 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride has high yield and high purity.
[0006] The inventive concept of the present invention is as follows: 1-chloro-5-fluoro-2-methyl-4-nitrobenzene is used as a starting material and reacts with isopropanol in an alkaline system to obtain compound a1; LiHMDS extracts hydrogen on C-4 of N-Boc-4-piperidinylcarboxylic acid methyl ester and reacts with compound a1 to obtain compound a2; compound a2 undergoes a hydrolysis reaction in an alkaline environment to obtain compound a3; compound a3 reacts in an acid agent, removes -Boc, and decarboxylates to obtain compound a4; compound a4 undergoes a reduction reaction with a reducing agent, and then hydrochloric acid is added to obtain the 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride. The starting raw materials of the invention are cheap and readily available, and no expensive raw materials are used in the entire preparation process, and precious metal palladium acetate and palladium carbon are not used for catalysis, so that the preparation cost is low; in addition, no dangerous compounds are used, and no dangerous reaction of hydrogen pressure reduction is involved, so the safety is high and suitable for scale-up production; and the prepared 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride has high yield and high purity, and the yield can reach nearly 60%, and the purity can be as high as 99.9%.
[0007] Therefore, the first aspect of the present invention provides a method for preparing 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride.
[0008] Specifically, the preparation method of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride comprises the following steps:
[0009] (1) reacting 1-chloro-5-fluoro-2-methyl-4-nitrobenzene and isopropanol in an alkaline system to obtain compound a1;
[0010] (2) Compound a1, methyl N-Boc-4-piperidincarboxylate, and LiHMDS react in a solvent to obtain compound a2;
[0011] (3) Compound a2 reacts in an alkali agent to obtain compound a3;
[0012] (4) Compound a3 reacts in an acid to obtain compound a4;
[0013] (5) Compound a4 reacts with a reducing agent, and then hydrochloric acid is added to obtain the 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride;
[0014] Wherein, the chemical formulas of compounds a1, a2, a3, and a4 are shown as (I), (II), (III), and (IV), respectively:
[0015]
[0016] Preferably, in step (1), the composition of the alkaline system includes at least one of potassium carbonate and cesium carbonate; further preferably, the composition of the alkaline system includes potassium carbonate and cesium carbonate.
[0017] Preferably, the mass ratio of potassium carbonate to cesium carbonate is 20:(0.7-1.1); further preferably, the mass ratio of potassium carbonate to cesium carbonate is 20:(0.8-1.0).
[0018] Preferably, in step (1), the usage ratio of 1-chloro-5-fluoro-2-methyl-4-nitrobenzene and isopropanol is 1 g:(4.0-6.0) mL; further preferably, the usage ratio of 1-chloro-5-fluoro-2-methyl-4-nitrobenzene and isopropanol is 1 g:(4.5-5.5) mL.
[0019] Preferably, in step (1), the reaction temperature is 75-95°C; further preferably, the reaction temperature is 80-90°C.
[0020] Preferably, in step (1), when the mass content of the raw material 1-chloro-5-fluoro-2-methyl-4-nitrobenzene is ≤0.5%, the reaction is terminated.
[0021] Preferably, in step (1), the reaction further comprises cooling and filtering processes after completion.
[0022] Preferably, after the filtration, the filter cake is rinsed with water, and the filter cake is collected and dried to obtain a1.
[0023] Preferably, step (2) is specifically as follows: firstly react the N-Boc-4-piperidinylcarboxylic acid methyl ester and LiHMDS in a solvent, and then add the compound a1 to react to obtain the compound a2.
[0024] Preferably, in step (2), the solvent comprises tetrahydrofuran.
[0025] Preferably, the mass ratio of the compound a1 to methyl N-Boc-4-piperidinol carboxylate is 1:(0.9-1.3); further preferably, the mass ratio of the compound a1 to methyl N-Boc-4-piperidinol carboxylate is 1:(1.0-1.2).
[0026] Preferably, the usage ratio of N-Boc-4-piperidinic acid methyl ester and LiHMDS is 1 g: (4.0-6.0) mL; further preferably, the usage ratio of N-Boc-4-piperidinic acid methyl ester and LiHMDS is 1 g: (4.5-5.5) mL.
[0027] Preferably, the reaction temperature of the N-Boc-4-piperidinic acid methyl ester and LiHMDS in the solvent is -17 to -4.5°C, and the reaction time is 25-35 min; more preferably, the reaction temperature is -15 to -5°C, and the reaction time is 27-33 min.
[0028] Preferably, in step (2), the reaction after adding the compound a1 includes a first reaction and a second reaction; the reaction temperature of the first reaction is -17 to -4.5°C, and the reaction time is 25-35 min; the reaction temperature of the second reaction is 9-22°C, and the reaction time is 9-11 h; further preferably, the reaction temperature of the first reaction is -15 to -5°C, and the reaction time is 27-33 min; the reaction temperature of the second reaction is 10-20°C, and the reaction time is 9.5-10.5 h.
[0029] Preferably, in step (2), the reaction is terminated when the mass content of the compound a1 is ≤1.0%.
[0030] Specifically, after the reaction of step (2) in the preparation method of the present invention is completed, step (3) can be continuously performed without performing a post-treatment step, thereby greatly improving production efficiency.
[0031] Preferably, in step (3), the alkaline agent includes at least one of sodium hydroxide and potassium hydroxide.
[0032] Preferably, step (3) further comprises adding alcohol; the alcohol comprises methanol.
[0033] Preferably, in step (3), the reaction temperature is 9-22°C; further preferably, the reaction temperature is 10-20°C.
[0034] Preferably, in step (3), the reaction is terminated when the mass content of compound a2 is ≤1.0%.
[0035] Preferably, in step (3), the reaction further includes extraction and reduced pressure concentration processes.
[0036] Preferably, after the extraction, an aqueous phase is obtained, and the pH of the aqueous phase is adjusted with an acid at a certain temperature, and then extraction is performed and concentrated under reduced pressure to obtain a3.
[0037] Preferably, the acid comprises hydrochloric acid.
[0038] Preferably, the pH is 2.5-4.5; further preferably, the pH is 3-4.
[0039] Preferably, the temperature is 0-11°C; further preferably, the temperature is 0-10°C.
[0040] Preferably, in step (4), the acidic agent comprises a hydrogen chloride solution, and the mass ratio of the hydrogen chloride solution to compound a3 is (0.55-1.1):1; further preferably, the mass ratio of the hydrogen chloride solution to compound a3 is (0.6-1.0):1.
[0041] Preferably, the hydrogen chloride solution is a hydrogen chloride / ethanol solution.
[0042] Preferably, in the hydrogen chloride solution, the mass fraction of hydrogen chloride is 25-37%; further preferably, in the hydrogen chloride solution, the mass fraction of hydrogen chloride is 28-34%; further preferably, in the hydrogen chloride solution, the mass fraction of hydrogen chloride is 31%.
[0043] Preferably, step (4) further comprises adding ethylene dichloride.
[0044] Preferably, in step (4), the reaction temperature is 60-80°C; further preferably, in step (4), the reaction temperature is 65-75°C.
[0045] Preferably, in step (4), the reaction ends when the mass content of compound a3 is ≤1.0%.
[0046] Preferably, in step (4), the reaction further comprises a process of concentrating under reduced pressure after completion.
[0047] Preferably, in step (5), the reducing agent includes hydrosulfur powder.
[0048] Preferably, in step (5), the mass ratio of the compound a4 to the reducing agent is 0.55-0.95; further preferably, the mass ratio of the compound a4 to the reducing agent is 0.60-0.85.
[0049] Preferably, in step (5), the reaction temperature is 55-75°C; further preferably, the reaction temperature is 60-70°C.
[0050] Preferably, in step (5), the reaction is terminated when the mass content of compound a4 is ≤1.0%.
[0051] Preferably, in step (5), the reaction further includes extraction and reduced pressure concentration processes.
[0052] Preferably, in step (5), the crude product is obtained after concentration under reduced pressure, and hydrochloric acid is added to obtain 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride.
[0053] Preferably, the hydrochloric acid is an acetonitrile / hydrogen chloride / ethanol solution.
[0054] Preferably, the mass fraction of hydrogen chloride is 1.5-2.5 mol / L; further preferably, the mass fraction of hydrogen chloride is 1.8-2.2 mol / L; further preferably, the mass fraction of hydrogen chloride is 2 mol / L.
[0055] Specifically, the structural formula of the 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride is:
[0056]
[0057] The second aspect of the present invention provides an application of the preparation method of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride described in the first aspect of the present invention in the preparation of ceritinib.
[0058] Compared with the prior art, the technical solution provided by the present invention has the following beneficial effects:
[0059] (1) The present invention uses 1-chloro-5-fluoro-2-methyl-4-nitrobenzene as a starting material and reacts with isopropanol in an alkaline system to obtain compound a1; LiHMDS extracts the hydrogen on C-4 of N-Boc-4-piperidinylcarboxylic acid methyl ester and reacts with compound a1 to obtain compound a2; compound a2 undergoes a hydrolysis reaction in an alkaline environment to obtain compound a3; compound a3 reacts in an acid agent to remove -Boc and decarboxylate to obtain compound a4; compound a4 undergoes a reduction reaction with a reducing agent, and then hydrochloric acid is added to obtain 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride. The starting raw materials of the invention are cheap and readily available, and no expensive raw materials are used in the entire preparation process, so that the preparation cost is low. In addition, the invention does not use dangerous compounds, has high safety, is suitable for scaled-up production, and the prepared 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride has high yield and high purity, the yield can reach nearly 60%, and the purity can be as high as 99.9%.
[0060] (2) Steps (2) and (3) in the preparation method of the present invention can be performed in two consecutive steps, which greatly reduces the time used for post-processing in each step and improves production efficiency.
[0061] (3) The synthesis process of the present invention is simple and easy to operate, and can react completely without pressurization, and can avoid the potential danger of hydrogen pressurized reduction, and has high safety. BRIEF DESCRIPTION OF THE DRAWINGS
[0062] Figure 1 The synthetic route of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride in Example 1 of the present invention is shown in FIG.
[0063] Figure 2This is the hydrogen nuclear magnetic resonance spectrum of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride in Example 1 of the present invention. DETAILED DESCRIPTION
[0064] In order to make the technical scheme of the present invention more clearly understood by those skilled in the art, the following embodiments are listed for illustration. It should be pointed out that the following embodiments do not limit the protection scope of the present invention.
[0065] Unless otherwise specified, the raw materials, reagents or devices used in the following examples can be obtained from conventional commercial sources or by existing known methods.
[0066] Example 1
[0067] The preparation method of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride comprises the following steps:
[0068] (1) Add isopropanol (500 mL), 2-chloro-4-fluoro-5-nitrotoluene (100.0 g), potassium carbonate (219.4 g) and cesium carbonate (10.0 g) to a three-necked flask, stir and heat to 85° C., start timing, keep the temperature for 18 hours, and start liquid chromatography HPLC monitoring. The reaction is completed when the content of 2-chloro-4-fluoro-5-nitrotoluene is ≤0.5%. After the reaction is completed, cool the temperature to 50° C., add water (600 mL), continue to cool to 25° C., keep for 1 hour, filter, rinse the filter cake with water, collect the filter cake and dry it to obtain a light yellow solid compound a1 (112.6 g, yield 93%);
[0069] (2) Add N-Boc-4-piperidinylcarboxylic acid methyl ester (116.5 g) and tetrahydrofuran (300 mL) to the reaction flask, replace with nitrogen three times, protect with nitrogen, cool to -10°C in a dry ice ethanol bath, then add 1.0 M LiHMDS (540 mL) dropwise, stir for 30 min after the addition is complete, and obtain mixture 1; dissolve compound a1 (100 g) in tetrahydrofuran (100 mL), add dropwise to mixture 1 at -10°C, keep stirring at -10°C for 30 min, then slowly heat to 15°C, continue stirring for 10 h, start HPLC monitoring, and when the content of compound a1 is ≤1.0%, the reaction is completed to obtain compound a2 with a yield of 93.3%; add methanol (150 mL) to compound a2 to obtain mixture 2, prepare KOH (20.9 g ) water (200 mL) solution, dropwise added into the mixture 2 system at a temperature of 15°C for hydrolysis reaction, stirred for 2 hours and monitored by HPLC, and the reaction was terminated when the content of compound a2 was ≤1.0%; after the reaction was completed, methyl tert-butyl ether (MTBE) (300 mL) was added for extraction, phase separation, and the aqueous phase was retained. The aqueous phase was adjusted to pH 3-4 with 3 mol / L hydrochloric acid aqueous solution at a temperature of 5°C, extracted twice with dichloromethane, and the organic phase was concentrated under reduced pressure until no obvious fraction was present to obtain viscous compound a3 (194.6 g), and the yield was calculated as 100% for the next reaction;
[0070] (3) Add dichloroethane (500 mL), compound a3 (194.6 g), and 31% hydrogen chloride / ethanol solution (115 g) to a three-necked flask, heat to 70° C., stir for 2 hours, and start HPLC monitoring. The reaction is completed when the content of compound a3 is ≤1.0%. The system is concentrated under reduced pressure until no obvious fraction is obtained to obtain brown viscous compound a4 (157.3 g). The yield is calculated as 100% and used for the next step reaction.
[0071] (4) Tetrahydrofuran (250 mL) and compound a4 (157.3 g) were added to a three-necked flask, and the temperature was raised to 65° C., and hydrosulfite (189.4 g) was added in batches. After stirring for 1.5 hours, HPLC monitoring was started. The reaction was terminated when the content of compound a4 was ≤1.0%. After the reaction was completed, water (150 mL) and MTBE (250 mL) were added for extraction, and the liquids were separated. The upper organic phase was collected, and the organic phase was concentrated under reduced pressure until no obvious fractions were obtained to obtain a crude product. The crude product was salified using acetonitrile / hydrogen chloride / ethanol solution, filtered, rinsed with acetonitrile, and dried to obtain the finished compound 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride (90.7 g). The yield of this step was 61.39%, the total yield was 57.09%, and the purity was 99.9%.
[0072] The synthetic route of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride in Example 1 is as follows: Figure 1 shown.
[0073] The hydrogen nuclear magnetic resonance spectrum of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride prepared in step (4) of Example 1 is as follows: Figure 2 As shown, Figure 2 The abscissa f1 (ppm) represents the chemical shift (ppm), and the nuclear magnetic resonance hydrogen spectrum characterization results are: 1 H NMR(500MHz,D2O)δ7.21(d,J=3.9Hz,1H),7.03(d,J=3.9Hz,1H),4.89–4.74(m,1H),3.55(s ,2H),3.18(s,3H),2.29(d,J=4.1Hz,3H),1.98(d,J=31.0Hz,2H),1.95(s,2H),1.32(s,6H).
[0074] Example 2
[0075] The preparation method of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride comprises the following steps:
[0076] (1) Add isopropanol (300 mL), 2-chloro-4-fluoro-5-nitrotoluene (60.2 g), potassium carbonate (131.64 g) and cesium carbonate (5.26 g) to a three-necked flask, stir and heat to 85°C, start timing, keep the temperature for 18 hours and start HPLC monitoring. The reaction is completed when the content of 2-chloro-4-fluoro-5-nitrotoluene is ≤0.5%. After the reaction is completed, cool the temperature to 50°C, add water (360 mL), continue to cool to 25°C, keep for 1 hour, filter, rinse the filter cake with water, collect the filter cake and dry it to obtain a light yellow solid compound a1 (66.47 g, yield 90.86%);
[0077] (2) Add N-Boc-4-piperidinylcarboxylic acid methyl ester (59.63 g) and tetrahydrofuran (160 mL) to the reaction flask, replace with nitrogen three times, protect with nitrogen, cool to -10°C using a dry ice ethanol bath, then add 1.0 M LiHMDS (540 mL) dropwise, stir for 30 min after the addition is complete, to obtain mixture 1, dissolve compound a1 (53.6 g) in tetrahydrofuran (55 mL), add dropwise to mixture 1 at -10°C, keep stirring at -10°C for 30 min, slowly raise the temperature to 15°C and stir for 10 h, start HPLC monitoring, and when the content of compound a1 is ≤1.0%, the reaction is completed to obtain compound a2; add methanol (150 mL) to compound a2 to obtain mixture 2, prepare NaOH (12. 1g) water (120mL) solution was added dropwise into the mixture 2 system at a temperature of 15°C for hydrolysis reaction, and the mixture was stirred for 2h and monitored by HPLC. The reaction was terminated when the content of compound a2 was ≤1.0%; after the reaction was completed, MTBE (150mL) was added for extraction, phase separation was performed, and the aqueous phase was retained. The pH of the aqueous phase was adjusted to 3-4 with a 3mol / L hydrochloric acid aqueous solution at a temperature of 5°C, and extracted twice with dichloromethane. The organic phase was concentrated under reduced pressure until there was no obvious fraction to obtain a viscous compound a3 (86.9g, yield 88.32%);
[0078] (3) Add dichloroethane (800 mL), compound a3 (310.37 g), and 31% hydrogen chloride / ethanol solution (263.8 g) to a three-necked flask, heat to 70° C., stir for 2 hours, and start HPLC monitoring. The reaction is terminated when the content of compound a3 is ≤1.0%. The system is concentrated under reduced pressure until no obvious fraction is present to obtain a brown oil compound a4 (195.23 g, yield 95.6%).
[0079] (4) Tetrahydrofuran (200 mL) and compound a4 (100.0 g) were added to a three-necked flask, the temperature was raised to 60° C., and hydrosulfite (156.4 g) was added in batches. The mixture was stirred for 1.5 hours and HPLC monitoring was started. The reaction was terminated when the content of compound a4 was ≤1.0%. After the reaction was completed, water (100 mL) was added and MTBE (200 mL) was used for extraction. The liquids were separated and the upper organic phase was collected. The organic phase was concentrated under reduced pressure until no obvious fractions were found to obtain a crude product. The crude product was salified using acetonitrile / hydrogen chloride / ethanol solution, filtered, rinsed with acetonitrile, and dried to obtain the finished compound 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride (87.6 g). The yield of this step was 72.2%, the total yield was 55.39%, and the purity was 99.9%.
[0080] Performance Testing
[0081] Chromatographic analysis
[0082] Liquid chromatography HPLC was used to perform chromatographic analysis on the 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride prepared in Example 1. The analysis conditions of HPLC are shown in Table 1.
[0083] Table 1: HPLC analysis conditions
[0084]
[0085]
[0086] Liquid chromatography analysis showed that the purity of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride prepared in Example 1 of the present invention was 99.9%.
[0087] In summary, the present invention uses 1-chloro-5-fluoro-2-methyl-4-nitrobenzene as a starting raw material, the starting raw material is cheap and easily available, the entire preparation process does not use expensive raw materials, and does not use precious metals such as palladium acetate and palladium carbon for catalysis, so that the preparation cost is low, and 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride has good yield and purity, the yield can reach nearly 60%, and the purity can be as high as 99.9%; in addition, the present invention does not use dangerous compounds, and does not involve dangerous reactions of hydrogen pressure reduction, has high safety, and is suitable for large-scale production.
[0088] The above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. A method for preparing 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride, It is characterized in that The following steps are involved: (1) reacting 1-chloro-5-fluoro-2-methyl-4-nitrobenzene and isopropanol in an alkaline system to obtain compound a1; (2) Compound a1, methyl N-Boc-4-piperidincarboxylate, and LiHMDS react in a solvent to obtain compound a2; (3) Compound a2 reacts in an alkali agent to obtain compound a3; (4) Compound a3 reacts in an acid to obtain compound a4; (5) Compound a4 reacts with a reducing agent, and then hydrochloric acid is added to obtain the 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline hydrochloride; Wherein, the chemical formulas of a1, a2, a3, and a4 are shown as (Ⅰ), (Ⅱ), (Ⅲ), and (Ⅳ), respectively:
2. The preparation method according to claim 1, It is characterized in that In step (1), the alkaline system comprises at least one of potassium carbonate and cesium carbonate.
3. The preparation method according to claim 1, It is characterized in that In step (1), the usage ratio of 1-chloro-5-fluoro-2-methyl-4-nitrobenzene and isopropanol is 1 g: (4.0-6.0) mL; and the reaction temperature is 75-95° C.
4. The preparation method according to claim 1, It is characterized in that Specifically, step (2) comprises first reacting the N-Boc-4-piperidinylcarboxylic acid methyl ester and LiHMDS in a solvent, and then adding the compound a1 to react to obtain the compound a2.
5. The preparation method according to claim 4, It is characterized in that The mass ratio of the compound a1 to N-Boc-4-piperidinic acid methyl ester is 1:(0.9-1.3).
6. The preparation method according to claim 4 or 5, It is characterized in that The dosage ratio of the N-Boc-4-piperidinic acid methyl ester and LiHMDS is 1 g: (4.0-6.0) mL.
7. The preparation method according to claim 1, It is characterized in that In step (3), the alkaline agent is selected from at least one of sodium hydroxide and potassium hydroxide; and the reaction temperature is 9-22°C.
8. The preparation method according to claim 1, It is characterized in that In step (4), the acid agent is a hydrogen chloride solution, and the mass ratio of the hydrogen chloride solution to compound a3 is (0.55-1.1):1; the reaction temperature is 60-80°C.
9. The preparation method according to claim 1, It is characterized in that In step (5), the reducing agent is hydrosulfur powder; the mass ratio of compound a4 to the reducing agent is (0.55-0.95):1; and the reaction temperature is 55-75°C.
10. Use of the preparation method according to any one of claims 1 to 9 in the preparation of ceritinib.
